NLARx News
Report on March 2009 NLARx Meeting More
|
In the States
VERMONT: Senate Passes Gift Ban Legislation More
MASSACHUSETTS: State Sets New Rules for Contact with Drug Industry More
IOWA: Senate Passes Gift Ban Bill More
MINNESOTA: Bill Banning Drug, Device Company Gifts to Doctors is Withdrawn by Sponsor More
NEW YORK: State Launches Rx Drug Card for Low-Income Consumers More
MARYLAND: Senate Votes Down Bill To Bolster Medicaid Fraud Investigations More
WASHINGTON: Lawsuit Prompts Delay in Medicaid Reimbursements for Brand Name Drugs More
MICHIGAN: House Passes Legislation to Repeal State's Rx Company Immunity Law More
TEXAS: Pharmacists Support Mail Order Drug Legislation, Negotiate Prompt Pay from PBMs More |
Outrage of the Week
Nearly All Authors of Psychiatric Guidelines Get Funding from Drug Makers More |
Fraud & Abuse
Former Drugmaker Sales Manager Pleads Guilty to Off-Label Marketing More
Federal Jury Convicts Disbarred Lawyers of Scam Over Diet-Drug Settlement More
Federal Court Gives Preliminary Approval To $894 Million Celebrex/Bextra Settlement More
Department of Justice Probing Promotional Practices for Megace More
|
Prices and Access to Healthcare
More Consumers Opting Not To Fill Prescriptions Because of Economic Pressures More
Wal-Mart in Talks With Several Companies To Expand Prescription Drug Discount Program for Employees More
Pharmaceutical Sales Growth Slowed In 2008, Prescription Data Firm Says More
Will Comparing Drugs Destroy America? More
Colorado Health Insurers Split Over Pill Cutting as Cost-Curbing Mechanism More |
Patents and Generics
More Prescriptions for Generics, Fewer for Branded Drugs More
BMS Pays $400 Million to Delay Generic Abilify More
FTC Commissioner Backs Bill to Ban Reverse Payments to Generic Makers More
House Panel Hears Testimony on Bill Banning Patent Settlement Payments To Delay Generic Drug Competition More
Senate Measure Would Allow Generic Versions of Biotechnology Drugs After Five Years More
Generic Pharmaceuticals Association Statement on Biogenerics Bill More
Bristol Settles Plavix Antitrust Probe with FTC More
Seizures of Generic Drugs Protested by Health Groups More
|
Advertising and Marketing
U.S. Supreme Court Asked to Review New Hampshire Data Mining Law More
FDA Warns 14 Drug Companies About Internet Ads Lacking Risk Info More
Another Job for FDA: Online Marketing Regulator More
FDA Warns 'One-Click Rule' Too Far For Risk Info in Online Drug Ads More
FDA Demands Pharmaceutical Firms Pull Unapproved Drugs More
FDA Cracks Down on Search-Engine Ads More
"Pharmacia Instrumental in Creating New Disease" Says Former VP More
Cephalon Seeks to Market Prescription Drug for Jet Lag More
Bill On 'Academic Detailing' Rx Data for Doctors Reintroduced in Congress More
GSK to Increase Disclosure of Payments to Health Providers, More
RealAge Backed by Big Pharma More
|
Conflicts of Interest
JAMA Article Recommends That Medical Groups Refuse Most Industry Funding More
Professional Medical Associations in JAMA: Drop Industry Funding More
AMA Wades Into Flap Over JAMA Editors More
Association of Health Care Journalists Objects to JAMA Disclosure Policy More
Questioning Industry Funding of Medical Specialty Societies More
American Psychiatric Association Phases Out Industry-Supported Events More
Stanford Medical School to Disclose More About Industry Comp More
Brown's Psych Chair Is Latest to Step Aside More
Doctors Urge Limits on Drug Firm Money More
|
Pharma Watch
Lipitor, Nexium Still Top-Selling Brands More
BMS Extends Partnership with Otsuka Pharmaceutical on U.S. Sales of Abilify More
Merger & Acquisition Trend Eliminating Scientists from Top Jobs in Pharma Cos. More
Drug Mergers Not About Innovation More
Eli Lilly Chief: Megamergers 'Driven by Weakness' More
Pfizer Will Reorganize R&D After Wyeth Merger More
Ranking Pharma's Highest-Paid Execs More
Merck CEO Calls On Pharma to Repair its 'Trust Deficit' More
Johnson & Johnson Wants a Piece of the Merck/Schering Action More
What's Ailing Big Pharma? More
|
PBM Watch
Court Rules Federal Law Preempts D.C. PBM Disclosure Law More
CVS Privacy Practices Need Investigation Despite FTC Order, Pharmacist Group Says More
|
Medicare & Medicaid
Large Drugstores Chains Can Resist Medicaid Reform More
State Attorneys General Support CMS On Off-Label Drug Use and Part D More
Health Care and Medicaid - Weathering the Recession More |
Safety and Clinical Trials
Clinical Trial Process Due for Reform More
Hospital Gets Subpoena Tied to Doctor's Faked Studies More
Caraco Recalls Heart Drug Due to Size Variability More
Watson Recalls One Lot of Generic Heart Drug More
FDA Seeks More Data on AstraZeneca's Symbicort More
Safe Drugs and the Cost of Good Intentions More
Comparing Drugs Is 'Real World' Demand, New PhRMA Head Says More
Charting a New Course at the FDA More
Rebooting the FDA More
Unbiased Research for Doctors Is Good Medicine More
Statins: Looking Beyond Their Effects on LDL Cholesterol More
Commonly Used Drugs Cause Confusion in Elderly More
St. Petersburg Times Examines Decline in Antipsychotic Drug Prescriptions for Florida Children More
|
Executive Branch Appointments
Sebelius Nomination May Shift to Slow Track More
GAO Official Names First 13 Members of HIT Policy Advisory Committee More
|
Electronic Records
Doctors and Hospitals Skip Electronic Records for the Same Reason: Cost More
Push for Digital Health Records Sparks Debate More
Significantly Fewer Hospitals Have Implemented Electronic Health Records Systems Than Estimated More
|
